# A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)

> **NCT06625814** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Levothyroxine
- **DRUG:** Enlicitide Decanoate

## Key facts

- **NCT ID:** NCT06625814
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-08
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-09-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06625814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06625814, "A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06625814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*